‘The odds were against me’: How an experimental pancreatic cancer vaccine changed a woman’s life
ClickOnDetroit | WDIV Local 4 • • health
Key Points:
- Donna Gustafson, a 72-year-old grandmother diagnosed with pancreatic cancer, is now cancer-free after receiving an experimental personalized mRNA vaccine at Memorial Sloan Kettering Cancer Center.
- The vaccine, tailored from the patient’s own tumor, trains the immune system to target specific cancer cells, similar to the technology used in COVID-19 vaccines.
- In a Phase 1 trial involving 16 patients, half showed a measurable response to the vaccine, with Gustafson remaining cancer-free six years later and maintaining high levels of vaccine-induced immune cells.
- Researchers hope this breakthrough in treating pancreatic cancer, one of the deadliest cancers, could lead to advancements in combating other cancer types.
- Gustafson’s survival has allowed her to celebrate significant personal milestones, including her 50th wedding anniversary and the birth of grandchildren, highlighting the profound impact of the treatment.
